Search

everythinglearnresearchcommunity

for

Search:↓

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Anabolic steroids harm the heart, liver, hormones, muscles, and mental health.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Women with PCOS have higher cardiometabolic risks.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.